Skip to main content
PepStack
Blutwerte · Marker

C-Peptid

C-Peptide · Connecting Peptide

Stoffwechsel & GlukoseNüchtern erforderlich
Einheit:
nmol/L
Abbreviation
C-Peptide

C-Peptide quantifies the amount of insulin produced endogenously by the pancreas.

Reference Ranges

Reference
0.260.62nmol/L
0.26
0.62
LowNormalHigh
Reference
Unit · nmol/L

Fasting sample preferred; renal function can affect levels.

Overview

Übersicht

C-Peptide, also known as Connecting Peptide, is a short polypeptide that connects the A and B chains of insulin in its proinsulin form. It is released into the bloodstream in equimolar amounts to insulin during the conversion of proinsulin to insulin, making it a useful marker for endogenous insulin production. Researchers have found that C-Peptide reflects beta-cell function and can be used to differentiate between types of diabetes, particularly in distinguishing type 1 from type 2 diabetes. Clinically, C-Peptide is important for assessing residual beta-cell function in diabetes management. Elevated levels may indicate insulin resistance or insulinoma, while low levels are often seen in type 1 diabetes due to autoimmune destruction of beta cells. In the context of athletic performance and biohacking, C-Peptide levels can provide insights into metabolic health and insulin sensitivity, which are crucial for optimizing energy utilization and recovery. However, the interpretation of C-Peptide levels can be confounded by factors such as renal function, as C-Peptide is cleared by the kidneys, and assay standardization issues. Time-of-day and fasting status can also influence measurements, necessitating standardized testing conditions to ensure accuracy.

Klinische Bedeutung

Elevated C-Peptide levels may indicate insulin resistance, insulinoma, or type 2 diabetes. Reduced levels are typically associated with type 1 diabetes or advanced type 2 diabetes with significant beta-cell dysfunction.

Dynamics

Trend Interpretation

Rising Values

Progressively rising C-Peptide levels suggest increasing insulin resistance or possible insulinoma. Re-test in 3-6 months if clinically indicated.

Falling Values

Progressively falling levels may indicate worsening beta-cell function, particularly in type 1 diabetes.

Re-test Interval

6 months if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Insulin resistance
  • Insulinoma
  • Renal failure
  • Obesity
  • Type 2 diabetes
Cause

Low Levels

  • Type 1 diabetes
  • Advanced type 2 diabetes
  • Pancreatic surgery
  • Severe beta-cell dysfunction
Protocol

How to Optimize

Lever

Lifestyle

  • Regular physical activity
  • Weight management
  • Stress reduction
Lever

Nutrition

  • Low glycemic index diet
  • High fiber intake

Note:

Consult physician before making significant lifestyle changes, especially if diabetic.

Testing Guidelines

🍽️Fasting Required
Not Time-Sensitive

Testing Frequency

Annually for diabetes management or as directed by a healthcare provider.

Interfering Factors

  • Renal impairment
  • Hemolysis
  • Assay variability

Related Peptides & Hormones

Insulin

Directly measures

hormone or peptide

Open Research Questions

Current research suggests that the clinical utility of C-peptide measurement in type 2 diabetes remains debated due to confounding factors like insulin resistance and the lack of standardized assays across laboratories. Researchers have not yet established optimal reference ranges or targets for C-peptide in diabetes management. Additionally, unanswered clinical questions include the precise role of C-peptide in differentiating diabetes types and its potential therapeutic applications in preventing end-organ damage.

21 Research Publications

613

Total Citations

5

Human/RCT

6.0

Avg. Influence

2024

Latest

Sort
Filter
#01

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.

ReviewInfluence17.0
196
This study examined guidelines for laboratory analysis in diagnosing and managing diabetes mellitus. Researchers found that various tests, including C-peptide measurement, can assist in understanding diabetes but some analytes have limited clinical value at present. The study emphasizes the need for evidence-based recommendations for effective diabetes management.
View on PubMed
#02

Proinsulin and C-peptide: a review.

ReviewInfluence5.0
138
This review focused on proinsulin and C-peptide, highlighting their roles in insulin synthesis. Researchers found that while proinsulin has some biological activity, C-peptide is biologically inert. Advances in measurement techniques have improved the assessment of C-peptide in clinical settings.
View on PubMed
#03

C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective.

ReviewInfluence4.0
103
This study explored the role of C-peptide in diagnosing and managing different types of diabetes. Researchers found that C-peptide levels reflect beta-cell function, aiding in diabetes classification and treatment decisions. However, the clinical utility of C-peptide in type 2 diabetes is limited due to insulin resistance and assay standardization issues.
View on PubMed
#04

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.

ReviewInfluence2.0
86
This study reiterated the importance of laboratory tests in diabetes management, including C-peptide measurement. Researchers found that while some tests are valuable, others are not recommended due to minimal clinical utility. The guidelines aim to provide clear recommendations for effective diabetes diagnosis and monitoring.
View on PubMed
#05

Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes.

Unknown
26
This study provided evidence for using C-peptide as a biomarker in type 1 diabetes clinical trials. Researchers found that C-peptide levels correlate with β-cell function and clinical outcomes, suggesting its potential as a meaningful measure for evaluating new therapies.
View on PubMed
#06

Evaluation of hemolysis, lipemia, and icterus interference with common clinical immunoassays.

In Vitro
20
This study evaluated how hemolysis, lipemia, and icterus affect clinical immunoassays, including C-peptide measurements. Researchers found that C-peptide levels can be significantly impacted by hemolysis, leading to potential inaccuracies in results. The study highlights the importance of understanding these interferences for accurate laboratory testing.
View on PubMed
#07

C-peptide in diabetes: A player in a dual hormone disorder?

ReviewInfluence2.0
15
This study investigated the multifunctional role of C-peptide in diabetes. Researchers found that C-peptide has protective effects in early diabetes stages but may promote complications in late stages. This dual role suggests C-peptide could be a valuable biomarker for understanding diabetes progression.
View on PubMed
#08

Insulin murder and the case of Colin Norris.

Human
9
This study examined the potential of C-peptide testing for early diagnosis of gestational diabetes. Researchers found that elevated C-peptide levels in early pregnancy could indicate a higher risk of developing gestational diabetes, suggesting a need for preventive strategies.
View on PubMed
#09

Interlaboratory Comparison of Antibody-Free LC-MS/MS Measurements of C-peptide and Insulin.

In Vitro
8
This study assessed the interlaboratory comparability of C-peptide measurements using LC-MS/MS. Researchers found that the method demonstrated high precision and linearity, suggesting it could improve standardization in diabetes research and patient care.
View on PubMed
#10

Hemolysis Affects C-Peptide Immunoassay.

In Vitro
8
This study examined the impact of hemolysis on C-peptide immunoassays. Researchers found that hemolysis negatively affects C-peptide measurement accuracy and developed a correction equation to improve result reliability. This advancement aims to enhance diagnostic accuracy in clinical practice.
View on PubMed

Publication Trend

Research publications about C-Peptid over time

9total
1
'77
1
'16
1
'22
3
'23
3
'24

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer